FONDO-LOW
Randomized, Double-Blind Study of FOND (Fosaprepitant, ONdansetron, Dexamethasone) Plus Either Olanzapine 2.5 Mg Versus 5 Mg for the Prevention of Chemotherapy Induced Nausea and Vomiting in Patients Receiving High-dose Melphalan Conditioning: the FONDO-LOW Study
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 3
- Enrollment
- 172 patients (estimated)
- Sponsors
- Augusta University Medical Center
- Tags
- Antipsychotic, Pre-Autologous Stem Cell Transplant, Randomization
- Trial Type
- Supportive
- Last Update
- 1 month ago
- SparkCures ID
- 1994
- NCT Identifier
- NCT06588413
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.